British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March ...

Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...

U.S. President Donald Trump said Tuesday he is likely to impose tariffs on pharmaceuticals as soon as the end of the month, ...

The investment is highlighted by a state-of-the-art API facility in Virginia and expansions across multiple states.